| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 17, 2003
Revised on May 2, 2003
Accepted on May 5, 2003
From the Departments of Surgery and Medicine and Community Medicine (T.T., L.J., G.C., N.M., R.G.S., D.K.D.), University of Connecticut School of Medicine, Farmington, Conn; and Pacific Northwest National Laboratory (J.E.M.), Richland, Wash.
* To whom correspondence should be addressed. E-mail: ddas{at}neuron.uchc.edu.
Hereditary hemochromatosis is an inherited pathological condition characterized by iron overload in several vital organs including heart. To increase our understanding of the underlying pathogenic mechanisms of hereditary hemochromatosis, we used a HFE gene knockout mouse model that replicates hereditary hemochromatosis. A group of mice with no copies of HFE gene and corresponding wild-type mice were maintained either on low-iron (30 ppm) or high-iron (300 ppm) diet since birth. The results of our study revealed that HFE gene knockout mouse hearts were susceptible to ischemia-reperfusion injury as evidenced by increased postischemic ventricular dysfunction, increased myocardial infarct size and cardiomyocyte apoptosis compared with wild-type control hearts. The degree of injury increased in the hearts of the rats fed high-iron diet. The hearts of the HFE knockout mice showed increased iron deposition, increased content of reactive oxygen species (ROS) as evidenced by the increased formation of malondialdehyde, and reduced antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase. The results suggest that increased amount of ROS and reduced antioxidant reserve secondary to iron overloading may be instrumental for the susceptibility of the HFE gene knockout mice to cardiac injury.
This article has been cited by other articles:
![]() |
U. Merle, E. Fein, S. G. Gehrke, W. Stremmel, and H. Kulaksiz The Iron Regulatory Peptide Hepcidin Is Expressed in the Heart and Regulated by Hypoxia and Inflammation Endocrinology, June 1, 2007; 148(6): 2663 - 2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Emara, R S El Kelany, and K A Moustafa Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats Human and Experimental Toxicology, July 1, 2006; 25(7): 375 - 385. [Abstract] [PDF] |
||||
![]() |
Y. Song, J. C. Shryock, S. Wagner, L. S. Maier, and L. Belardinelli Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 214 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Valenti, D Conte, A Piperno, P Dongiovanni, A L Fracanzani, M Fraquelli, A Vergani, C Gianni, L Carmagnola, and S Fargion The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis J. Med. Genet., December 1, 2004; 41(12): 946 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McCord Iron, Free Radicals, and Oxidative Injury J. Nutr., November 1, 2004; 134(11): 3171S - 3172S. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |